NGNE
Neurogene Inc.
NASDAQ · USHealthcareBiotechnology
$37.34+0.08%
Price as of Jul 20, 2026
NGNE valuation
Neurogene Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 2.48x
- Price / sales
- —
- Price / cash flow
- -7.20x
Enterprise value
- Enterprise value
- $356.0M
- EV / sales
- —
- EV / EBITDA
- -3.73x
- EV / EBIT
- -3.21x
- Market cap
- $590.0M
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.